Author:
Velez Nicole F.,Wei-Passanese Erin X.,Husni M. Elaine,Mody Elinor A.,Qureshi Abrar A.
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference41 articles.
1. Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P et al (2006) Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Rheumatology 45(8):1029–1038
2. Barra L, Pope JE, Payne M (2009) Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire. J Rheumatol 36(7):1421–1428
3. Berthelot JM, Klarlund M, McGonagle D, Bernelot-Moens HJ, Calin A, Harrison B et al (2001) Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group. J Rheumatol 28(5):975–981
4. Boehncke S, Fichtlscherer S, Salgo R, Garbaraviciene J, Beschmann H, Diehl S et al (2011) Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Arch Dermatol Res 303(6):381–388
5. Chandran V, Schentag CT, Gladman DD (2008) Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol 35(10):2069–2070
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献